Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History → America’s worst nightmare? (From Porter & Company) (Ad) Free AVTE Stock Alerts $19.28 +0.14 (+0.73%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Aerovate Therapeutics Stock Price Performance5 Day Performance-2.77%1 Month Performance-23.79%3 Month Performance-10.91%6 Month Performance+32.33%Year-To-Date Performance-14.80%1 Year Performance-8.54% Receive AVTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Monetary GoldDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. AVTE Stock Chart for Wednesday, May, 15, 2024 AVTE Chart by TradingView Aerovate Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$19.14$19.28+0.73%$20.56$18.39246,860 shs$537.91 million05/13/2024$19.83$19.14-3.48%$19.96$18.83230,768 shs$534.01 million05/10/2024$21.56$19.83-8.02%$21.68$19.5979,129 shs$553.26 million05/09/2024$21.04$21.56+2.47%$21.78$20.51128,462 shs$601.52 million05/08/2024$20.44$21.04+2.94%$21.20$19.82137,134 shs$587.02 million05/07/2024$20.62$20.44-0.87%$20.79$19.79142,515 shs$570.28 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$20.29$20.62+1.63%$20.86$20.22111,049 shs$592.56 million05/03/2024$20.75$20.29-2.22%$22.34$19.9999,949 shs$583.14 million05/02/2024$20.84$20.75-0.43%$21.21$20.21127,568 shs$596.36 million05/01/2024$20.01$20.84+4.15%$21.75$19.73152,803 shs$575.03 million04/30/2024$20.55$20.01-2.63%$20.69$19.6574,938 shs$557.48 million04/29/2024$21.75$20.55-5.52%$22.04$20.5156,084 shs$572.52 million04/26/2024$21.57$21.75+0.83%$22.39$21.1274,007 shs$605.96 million04/25/2024$21.20$21.57+1.75%$22.13$19.83119,830 shs$600.94 million04/24/2024$23.22$21.20-8.70%$23.93$21.10304,305 shs$590.63 million04/23/2024$22.17$23.22+4.74%$23.75$21.37148,258 shs$646.91 million04/22/2024$22.05$22.17+0.54%$22.87$21.35109,562 shs$617.66 million04/19/2024$21.60$22.05+2.08%$22.41$20.73218,786 shs$614.31 million04/18/2024$22.50$21.60-4.00%$22.44$20.96216,299 shs$601.78 million04/17/2024$23.62$22.50-4.74%$23.97$21.81159,191 shs$626.85 million04/16/2024$25.30$23.62-6.64%$25.58$23.47132,905 shs$658.05 million04/15/2024$25.24$25.30+0.24%$25.35$24.32106,784 shs$704.86 million04/12/2024$26.89$25.24-6.14%$27.11$24.44133,111 shs$703.19 million04/11/2024$27.01$26.89-0.44%$27.05$26.53142,551 shs$749.16 million04/10/2024$28.05$27.01-3.71%$27.79$26.22223,391 shs$752.50 million04/09/2024$26.48$28.05+5.93%$28.68$26.41132,128 shs$781.47 million04/08/2024$25.05$26.48+5.71%$26.58$24.51119,804 shs$737.73 million04/05/2024$29.10$25.05-13.92%$28.00$24.43246,223 shs$697.89 million04/04/2024$29.12$29.10-0.07%$30.29$28.77153,814 shs$810.73 million04/03/2024$29.58$29.12-1.56%$30.23$28.27179,635 shs$811.28 million04/02/2024$30.75$29.58-3.80%$29.97$28.45169,282 shs$824.10 million04/01/2024$29.57$30.75+3.99%$32.42$28.29295,749 shs$856.70 million03/29/2024$29.57$29.57$29.99$27.10216,915 shs$823.82 million03/28/2024$28.50$29.57+3.75%$29.99$27.10216,915 shs$823.82 million03/27/2024$25.65$28.50+11.11%$29.36$25.62922,344 shs$788.60 million03/26/2024$26.95$25.65-4.82%$27.32$24.27271,347 shs$709.74 million03/25/2024$25.78$26.95+4.54%$28.39$26.26224,601 shs$745.71 million03/22/2024$26.00$25.78-0.85%$26.78$25.4090,512 shs$713.33 million03/21/2024$25.89$26.00+0.42%$27.00$25.69188,505 shs$719.42 million03/20/2024$25.72$25.89+0.66%$27.34$25.36102,945 shs$716.38 millionTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late.03/19/2024$26.39$25.72-2.54%$26.97$25.07100,094 shs$711.65 million03/18/2024$26.70$26.39-1.16%$27.12$25.24191,434 shs$730.21 million03/15/2024$24.29$26.70+9.92%$27.37$24.41105,613 shs$738.79 million03/14/2024$26.98$24.29-9.97%$26.87$23.9573,639 shs$672.08 million03/13/2024$24.14$26.98+11.76%$27.82$23.06104,171 shs$746.54 million03/12/2024$24.77$24.14-2.54%$25.20$23.28302,228 shs$667.95 million03/11/2024$26.52$24.77-6.60%$26.35$24.13124,970 shs$685.39 million03/08/2024$24.40$26.52+8.69%$27.20$23.52105,083 shs$733.81 million03/07/2024$23.87$24.40+2.22%$25.85$23.46143,651 shs$675.15 million03/06/2024$22.84$23.87+4.51%$24.10$22.3742,483 shs$660.48 million03/05/2024$22.49$22.84+1.56%$23.22$22.0644,281 shs$631.98 million03/04/2024$23.83$22.49-5.62%$23.96$22.4251,021 shs$622.30 million03/01/2024$23.08$23.83+3.25%$24.24$22.20108,483 shs$659.38 million02/29/2024$23.09$23.08-0.04%$24.17$22.3351,983 shs$638.60 million02/28/2024$23.77$23.09-2.86%$24.19$22.2251,375 shs$638.90 million02/27/2024$20.74$23.77+14.61%$24.49$19.99163,559 shs$657.72 million02/26/2024$19.63$20.74+5.65%$21.63$18.0870,687 shs$573.88 million02/23/2024$18.82$19.63+4.30%$20.10$18.8182,065 shs$543.16 million02/22/2024$18.85$18.82-0.16%$19.20$18.3995,812 shs$520.75 million02/21/2024$18.80$18.85+0.27%$19.44$18.11184,675 shs$521.58 million02/20/2024$20.91$18.80-10.09%$21.00$18.08219,186 shs$520.20 million02/19/2024$20.91$20.91$22.28$20.8180,200 shs$578.56 million02/16/2024$21.64$20.91-3.37%$22.28$20.8180,254 shs$578.58 million02/15/2024$19.25$21.64+12.42%$21.69$18.4765,784 shs$598.76 million02/14/2024$19.00$19.25+1.32%$19.86$18.0843,059 shs$532.65 million Related Companies: Arbutus Biopharma Stock Chart IGM Biosciences Stock Chart Y-mAbs Therapeutics Stock Chart Applied Therapeutics Stock Chart KalVista Pharmaceuticals Stock Chart Verve Therapeutics Stock Chart Altimmune Stock Chart Astria Therapeutics Stock Chart SIGA Technologies Stock Chart COMPASS Pathways Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.